Tyra Biosciences (TYRA) stock, explained like you're 5

Is Tyra Biosciences a small, medium or large cap company?

No. Tyra Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.4 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Tyra Biosciences makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves TYRA stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• Tyra Biosciences, Inc. (TYRA) Stock Price, News, Quote & History (Yahoo! Finance Canada)
• Tyra Biosciences, Inc. Rings the Nasdaq Stock Market Opening Bell (Nasdaq)
• Tyra Biosciences (TYRA) Stock Looks Expensive Against Its Book Value (Yahoo Finance)
• Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock (Fierce Biotech)
• Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre Funded Warrants (PR Newswire)

Key terms to know before you follow TYRA

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility